Antisense Therapeutics
安天圣施
Antisense Therapeutics
Biotech/Healthcare
Suzhou Antisense Therapeutics Co., Ltd., located in Suzhou Industrial Park, is China’s first company to develop antisense oligonucleotide (ASO) drugs targeting RNA splicing and RNA editing. It owns multiple internationally advanced ASO technologies and has several programs underway, including drug…
Latest round: Series A (2024)
Source: ChinaBulls — chinabulls.com
Last updated 2024-07-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.